Planet Labs Q2FY27 Earnings Preview: Defense growth, backlog in focus
- Planet Labs reports Q2FY27 earnings on September 3; analysts estimate $104.12M revenue.
- Defense segment grew >65% YoY last quarter, driving primary growth.
- Backlog rose >70% YoY to $906M as of Q1 end.
- Stock trades 27.3% below 200-day SMA amid bearish technical setup.

*this image is generated using AI for illustrative purposes only.
Planet Labs PBC (NYSE: PL) is set to report second-quarter fiscal-year 2027 earnings on September 3 after market close. Investors are closely monitoring the company's defense segment expansion and order backlog as key indicators of future revenue visibility.
Earnings Estimates and Prior Performance
Analysts project a loss of 2 cents per share for the quarter, alongside revenue estimates of $104.12 million. This follows a strong prior quarter where Planet Labs reported an EPS of negative 3 cents, beating the consensus estimate of negative 4 cents by 25%. Revenue for that period stood at $94.15 million, surpassing the consensus estimate of $89.85 million by 4.78%.
Backlog and Segment Growth
The defense and intelligence segment remains the primary growth driver, having expanded more than 65% year-over-year in the previous quarter. Investors will track updates on international contract wins and the pace of Pelican satellite deployments.
Key visibility metrics at the end of the first quarter included:
| Metric | Value | YoY Change |
|---|---|---|
| Backlog | $906 million | >70% |
| Remaining Performance Obligations | $816 million | >70% |
Full-year fiscal 2027 guidance remains set at revenue between $425 million and $441 million. Adjusted EBITDA guidance ranges from breakeven to $10 million, with management focusing on progress toward sustained positive free cash flow.
Technical Setup
Planet Labs shares are trading below all major moving averages, signaling a defensive technical posture. The stock trades:
- 13.8% below its 20-day SMA
- 19.6% below its 50-day SMA
- 37.7% below its 100-day SMA
- 27.3% below its 200-day SMA
A death cross occurred in August, with the 50-day SMA falling below the 200-day SMA. The MACD indicator sits below its signal line with a negative histogram, suggesting fading upside momentum.
Key Price Levels
Near-term trading levels are tight ahead of the earnings release:
- Key Resistance: $21.00 — A round-number area that may cap rebounds.
- Key Support: $19.50 — A nearby floor traders may defend.
At the time of publication, Planet Labs shares were trading 1.91% lower at $19.47.
How might the pace of Pelican satellite deployments influence Planet Labs' ability to convert its $906 million backlog into recognized revenue in fiscal 2027?
Could a beat on Q2 earnings estimates trigger a technical reversal despite the recent death cross and negative MACD momentum?
What specific international defense contracts are expected to drive the continued >65% YoY growth in the defense and intelligence segment?

































